75 related articles for article (PubMed ID: 12390542)
1. Characterization of CD4+ T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virus.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Med Primatol; 2002 Aug; 31(4-5):194-204. PubMed ID: 12390542
[TBL] [Abstract][Full Text] [Related]
2. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
[TBL] [Abstract][Full Text] [Related]
3. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus.
Dittmer U; Feldmann G; Sauermann U; Spirng M; Uberla K; Stahl-Hennig C; Hunsmann G
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1801-7. PubMed ID: 9680145
[TBL] [Abstract][Full Text] [Related]
4. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
5. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer.
Kuroda MJ; Schmitz JE; Lekutis C; Nickerson CE; Lifton MA; Franchini G; Harouse JM; Cheng-Mayer C; Letvin NL
J Virol; 2000 Sep; 74(18):8751-6. PubMed ID: 10954578
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques.
Vargas-Inchaustegui DA; Demers A; Shaw JM; Kang G; Ball D; Tuero I; Musich T; Mohanram V; Demberg T; Karpova TS; Li Q; Robert-Guroff M
J Immunol; 2016 Feb; 196(4):1700-10. PubMed ID: 26773147
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.
Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541
[TBL] [Abstract][Full Text] [Related]
9. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
10. Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge.
Lifson JD; Piatak M; Rossio JL; Bess J; Chertova E; Schneider D; Kiser R; Coalter V; Poore B; Imming R; Desrosiers RC; Henderson LE; Arthur LO
J Med Primatol; 2002 Aug; 31(4-5):205-16. PubMed ID: 12390543
[TBL] [Abstract][Full Text] [Related]
11. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
Rybarczyk BJ; Montefiori D; Johnson PR; West A; Johnston RE; Swanstrom R
J Virol; 2004 Apr; 78(7):3561-71. PubMed ID: 15016879
[TBL] [Abstract][Full Text] [Related]
12. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK
Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820
[TBL] [Abstract][Full Text] [Related]
13. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
14. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
[TBL] [Abstract][Full Text] [Related]
15. A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.
Patterson LJ; Robey F; Muck A; Van Remoortere K; Aldrich K; Richardson E; Alvord WG; Markham PD; Cranage M; Robert-Guroff M
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):837-49. PubMed ID: 11429125
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
18. Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model.
Mori K; Sugimoto C; Ohgimoto S; Nakayama EE; Shioda T; Kusagawa S; Takebe Y; Kano M; Matano T; Yuasa T; Kitaguchi D; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; Yamamoto N; Suzuki Y; Nagai Y
J Virol; 2005 Aug; 79(16):10386-96. PubMed ID: 16051831
[TBL] [Abstract][Full Text] [Related]
19. Characterization of SIV-specific CD4+ T-helper proliferative responses in macaques immunized with live-attenuated SIV.
Gauduin MC; Glickman RL; Ahmad S; Yilma T; Johnson RP
J Med Primatol; 1999; 28(4-5):233-41. PubMed ID: 10593490
[TBL] [Abstract][Full Text] [Related]
20. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.
Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL
J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
